Dyne Therapeutics Aktie
WKN DE: A2QB6B / ISIN: US26818M1080
|
21.11.2025 21:43:07
|
Why Dyne Therapeutics Stock Was Crushing it This Week
One of the healthier stocks over the past several days has been biotech Dyne Therapeutics (NASDAQ: DYN). The company received a positive mention in a broader analyst note on its sector, and investors took this to heart. They traded up the stock to the point where it was 11% higher week-to-date late in Friday's session, according to data compiled by S&P Global Market Intelligence. That research note was published on Sunday, setting the tone for Dyne (and other mentioned healthcare stocks) for the remainder of the week.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Dyne Therapeutics Inc Registered Shsmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Dyne Therapeutics Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
| Dyne Therapeutics Inc Registered Shs | 21,18 | 5,27% |
|